Intensive Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

23 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-08-01

Study Completion Date

2016-12-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is investigating the efficacy of an intensive (3 week) integrated treatment for Veterans with both pain and PTSD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Integrated Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)

NCT00127413

Pain Posttraumatic Stress Disorder

COMPLETED NA

Improving Psychosocial Functioning in Older Veterans With PTSD

NCT02803125

Posttraumatic Stress Disorder

COMPLETED NA

Integrated PTSD and Chronic Pain Treatment

NCT07225049

PTSD Chronic Pain

RECRUITING NA

An Adjunctive Family Intervention for Individual Posttraumatic Stress Disorder Treatment

NCT02956434

Posttraumatic Neuroses

COMPLETED NA

Integrated vs Sequential Treatment for PTSD and Addiction

NCT01211106

PTSD Substance Addiction

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objectives:

The primary objective of this study is to evaluate the efficacy of an intensive integrated treatment for Veterans with comorbid chronic pain and posttraumatic stress disorder (PTSD). A secondary objective is to examine potential mechanisms of action that might account for improvements in pain or PTSD. Third, exploratory analyses will be conducted to assess the relationship between participation in treatment and cognitive functioning. It is hypothesized that 1) participants receiving the intensive treatment (PT) will report significantly greater decreases in symptoms of pain and PTSD from pre-treatment to post-treatment when compared to participants randomized to a standard care (SC) condition, and 2) participants receiving PT will show greater maintenance of change on measures of pain and PTSD at 3 months following the completion of treatment when compared to participants randomized to the SC condition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stress Disorders, Post-Traumatic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intensive Treatment

Intensive 3 week treatment for pain and PTSD. This includes elements of Cognitive Processing Therapy and CBT for Chronic Pain

Group Type EXPERIMENTAL

Intensive Treatment

Intervention Type BEHAVIORAL

Participants randomized to the Intensive Treatment condition will attend 6 bi-weekly outpatient therapy sessions conducted in an individual format of 90 minutes in duration.

Treatment as Usual

Treatment as Usual. Participants are eligible for all treatment services as needed except for treatment of pain or PTSD

Group Type EXPERIMENTAL

Treatment as Usual

Intervention Type BEHAVIORAL

Treatment as Usual.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intensive Treatment

Participants randomized to the Intensive Treatment condition will attend 6 bi-weekly outpatient therapy sessions conducted in an individual format of 90 minutes in duration.

Intervention Type BEHAVIORAL

Treatment as Usual

Treatment as Usual.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients will be eligible to participate if they have constant pain of at least three months duration with a neurologic or musculoskeletal etiology.
* Patients must also meet diagnostic criteria for PTSD.

Exclusion Criteria

* Patients with life threatening or acute physical illness, current alcohol or substance abuse, current psychosis or suicidal ideation, and individuals seeking pain treatment such as surgical interventions will be excluded.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No